SCHEMBL6216766

SCHEMBL6216766

O=Cc1nc2ccc(F)cc2c(=O)n1-c1ccccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6601764 0.86 — —
SCHEMBL6601768 0.86 — —
SCHEMBL6216663 0.86 TDO2 (0.48) —
SCHEMBL8300710 0.85 TP53 (0.63) —
SCHEMBL8300712 0.85 TP53 (0.63) —
Water SCHEMBL6217170 0.85 TDO2 (0.47) —
SCHEMBL6214003 0.85 TDO2 (0.57) —
SCHEMBL6215609 0.84 LMNA (0.67) —
SCHEMBL6215340 0.84 — —
SCHEMBL6215343 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0884310-B1 Quinazolin-4-one ampa antagonists PFIZER PROD INC (US) 2005-09-07 — — EP disclosed
US-6921764-B2 Thieno-pyrimidin-4-one AMPA antagonists PFIZER INC. (US) 2005-07-26 — — US disclosed
US-20040049039-A1 Quinazolin-4-one ampa antagonists PFIZER INC 2004-03-11 — — US disclosed
US-6627755-B1 Neurodegenerative, psychological, and nervous system disorder; drug abuse, alcoholism PFIZER INC 2003-09-30 — — US disclosed
EP-0884310-A1 Quinazolin-4-one ampa antagonists Pfizer Products Inc. (US) 1998-12-16 — — EP disclosed
Send feedback